Status: current, Primitive. Date: 30-Sep 2020. Module: SNOMED Clinical Terms Australian extension
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4461361000168118 | Paramethoxyamphetamine (substance) | en | Fully specified name | Active | Case insensitive | SNOMED Clinical Terms Australian extension |
| 4461371000168112 | Paramethoxyamphetamine | en | Synonym | Active | Case insensitive | SNOMED Clinical Terms Australian extension |
| 4461381000168110 | PMA - Paramethoxyamphetamine | en | Synonym | Active | Case sensitive | SNOMED Clinical Terms Australian extension |
| 4461391000168113 | 4MA - 4-methoxyamphetamine | en | Synonym | Active | Case sensitive | SNOMED Clinical Terms Australian extension |
| 4461401000168110 | p-methoxyamphetamine | en | Synonym | Active | Case sensitive | SNOMED Clinical Terms Australian extension |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Paramethoxyamphetamine | Is a | Hallucinogenic agent | true | Inferred relationship | Some | ||
| Paramethoxyamphetamine | Is a | Amfetamine and/or amfetamine derivative | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Substance foundation reference set
FHIR